600267 Zhejiang Hisun Pharmaceutical

Watchlist

Trading Jan 8 10:46 CST

9.43BMarket Cap-462.94P/E (TTM)

Zhejiang Hisun Pharmaceutical Key Stats

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/FY	-- / 9.920B	--
--	2024/FY	-- / 9.487B	--
--	2023/FY	10.373B / 12.647B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/FY-- / 9.920B--

--2024/FY-- / 9.487B--

--2023/FY10.373B / 12.647B--

--------

Unlock Free Earnings Estimates

Open Account

Haizheng Pharmaceutical: Zhejiang Haizheng Pharmaceutical Co., Ltd. Report for the Third Quarter of 2024

Oct 30, 2024 12:00 ET

Zhejiang Haizheng Pharmaceutical Co., Ltd. Report for the Third Quarter of 2024

Oct 30, 2024 12:00 ET

Zhejiang Hisun Pharmaceutical Co., Ltd. 2024 Interim Report

Aug 19, 2024 12:00 ET

Summary of Zhejiang Hisun Pharmaceutical Co., Ltd.'s 2024 interim report.

Aug 19, 2024 12:00 ET

Overall

No Data